Cosmos Health Inc. (COSM): debt financing — Cosmos Health secures up to $300M convertible note facility for Ethereum treasury strategy

Cosmos Health Inc.

Up to $300M in 9% senior secured convertible notes; initial $8M close on Aug 6, 2025.
72.5% of net proceeds to be used to acquire Ethereum (ETH) as a digital asset treasury reserve.
Shares convertible at market-based pricing; beneficial ownership cap of 4.99% (can increase to 9.99%).
Company must call shareholder meeting within 60 days to approve increase in authorized shares to 1.5B.
Remaining proceeds for working capital, R&D, and U.S. manufacturing expansion; Curvature Securities placement agent.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cosmos Health Inc. incurred convertible notes of $300,000,000 with an institutional investor at 9% per annum maturing twenty four (24) months after its respective issuance date.

Instrument: convertible notes
Principal: $300,000,000
Counterparty: an institutional investor
Rate: 9% per annum
Maturity: twenty four (24) months after its respective issuance date
Event: incurrence

Exact text from the filing

the Company agreed to issue and sell to the Purchaser a series of 9% original issue discount senior secured convertible promissory notes (each, a “ Note ” and collectively, the “ Notes ”) in the maximum aggregate principal amount of $300,000,000 (the “ Note Offering ”)

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-25-005501

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.